Cargando…
Complement Factor H in cSCC: Evidence of a Link Between Sun Exposure and Immunosuppression in Skin Cancer Progression
Cutaneous squamous cell carcinoma (cSCC) is a common form of skin cancer with an estimated 750,000 cases diagnosed annually in the United States. Most cases are successfully treated with a simple excision procedure, but ~5% of cases metastasize and have a 5-year survival rate of 25-45%. Thus, identi...
Autores principales: | Johnson, Ellise M., Uppalapati, Chandana K., Pascual, Agnes S., Estrada, Sarah I., Averitte, Richard L., Leyva, Kathryn J., Hull, Elizabeth E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869607/ https://www.ncbi.nlm.nih.gov/pubmed/35223500 http://dx.doi.org/10.3389/fonc.2022.819580 |
Ejemplares similares
-
A Hybrid Epithelial to Mesenchymal Transition in Ex Vivo Cutaneous Squamous Cell Carcinoma Tissues
por: Pulford, Christopher S., et al.
Publicado: (2022) -
Biomarker Discovery in Rare Malignancies: Development of a miRNA Signature for RDEB-cSCC
por: Zauner, Roland, et al.
Publicado: (2023) -
Current Surgical Therapy of Locally Advanced cSCC: From Patient Selection to Microsurgical Tissue Transplant. Review
por: Brambullo, Tito, et al.
Publicado: (2021) -
TRAF6 regulates EGF-induced cell transformation and cSCC malignant phenotype through CD147/EGFR
por: Zhang, Xu, et al.
Publicado: (2018) -
Loss of retinoic acid receptor-related receptor alpha (Rorα) promotes the progression of UV-induced cSCC
por: Zhang, Guolong, et al.
Publicado: (2021)